Navigation Links
"Blood Therapy" Has Patients Flocking to Washington DC's Pioneering Pain Doctor
Date:6/11/2013

WASHINGTON, June 11, 2013 /PRNewswire/ -- Platelet-Rich Plasma (PRP) is a little-known treatment discovered by the athletic elite in 2009. A radical treatment for sports related and other chronic injuries, it uses a patient's own blood to aid in the healing of itself. With growing buzz created by former "blood therapy" recipients; pro golfer, Tiger Woods and NBA star, Kobe Bryant, PRP is fast becoming the exciting alternative to surgery that more pain patients are looking for. A handful of doctors in the United States and only a few in the Washington Metropolitan area have extensive experience in this revolutionary procedure, that's why Pain Management Specialist G. Hudson Drakes of Metro Spine is in such high demand. "If more people knew that they could get relief from chronic pain without painful surgery and without drugs using their body's own healing mechanisms, they wouldn't hesitate," says Drakes, "it's a non-invasive alternative worth exploring."

What is PRP?
PRP is when a small amount of blood is taken from the patient's arm and placed in a special centrifuge. The centrifuge spins and separates platelets from the rest of the blood components. The process of preparing the Platelet-Rich Plasma takes less than 15 minutes and increases the concentration of platelets and growth factors up to 600%. Using your own blood, specially prepared platelets are taken and re-injected into the affected area using image-guided fluoroscopy ultrasound imaging. These platelets release special growth factors that lead to tissue healing. By using the concentrated platelets, growth factors increase up to eight times which promotes temporary relief, stops inflammation, and heals the area over a period of time. PRP has been proven to benefit patients with arthritis, degenerative joint disease, golfer & tennis elbo w, hip pain, knee pain, shoulder pain, sports injuries, tendonitis, and more.

Dr. Drakes, a board-certified specialist in physical medicine & rehabilitation, is a Diplomate of The American Board of Pain Medicine, and an academic professor and lecturer. Dr. Drakes founded Metro Spine Pain Centers in 1993 to make a difference in the lives of people who have chronic pain conditions. He leads a team of top professionals whose advanced care and innovative approach has brought relief to thousands of people.

CONTACT:
Sonya A. Lowery
sonyal@metrospinemd.com
202.375.9209


'/>"/>
SOURCE Metro Spine
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
2. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
3. Phreesia identifies over 26% of patients who require additional autism evaluation
4. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
5. New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease
6. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
7. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
8. Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients
9. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
10. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
11. CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- Dublin ... the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global market ... its applications in various applications. The report deals with ... main industries: pharmaceutical and biotechnology, food and beverage, and ...
(Date:6/24/2016)... ANDOVER, Mass. and SAN CLEMENTE, Calif. ... California -based mobile pulmonary function testing company, is now ... portable PFT devices developed by ndd Medical Technologies , Inc. ... PFT testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ... CA , can get any needed testing done in the ...
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Venture Construction ... Classic Tournament held on June 20th at the Woodmont Country Club at 1201 ... Wings, an organization dedicated to helping service members that have been wounded in battle ...
(Date:6/24/2016)... ... June 24, 2016 , ... Southern Illinois ... are co-chairs for the Illinois State Dental Society (ISDS) Foundation’s Mission of Mercy ... Gateway Convention Center in Collinsville. , They expect to treat approximately ...
(Date:6/23/2016)... Los Angeles, CA (PRWEB) , ... June 23, 2016 , ... ... being conducted that may expose a possible link between head and neck cancer in ... individuals participating in the study were evaluated based on whether they had gum disease, ...
(Date:6/23/2016)... ... ... Representatives of CHA Fertility Centers (CFC), one of the largest fertility treatment ... Berger. As of May 2016, Dr. Berger will serve as the Medical Director ... recognition for his research, his teaching and his patient care. After 15 years in ...
Breaking Medicine News(10 mins):